CLINICAL_TRIALS
trial_result
· 2024-12-24
Clinical Trial Update: Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Summary
A Phase 1 clinical trial evaluating FF-10101-01 in adults with relapsed or refractory acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. | Conditions: AML, Adult | Phase 1 | Status: COMPLETED